In light of this information gap, we retrospectively analyzed electronic medical record (EMR) data to investigate the association between CYP2C19 metabolizer status and treatment outcomes following inpatient psychiatric hospitalization in youth with anxiety and/or depressive disorders. The gene discussed is CYP2C19; the disease is Anxiety.